Evaluation of the Tg.AC Transgenic Mouse Assay for Testing the Human Carcinogenic Potential of Pharmaceuticals—Practical Pointers, Mechanistic Clues, and New Questions
- 1 January 2002
- journal article
- research article
- Published by SAGE Publications in International Journal of Toxicology
- Vol. 21 (1) , 65-79
- https://doi.org/10.1080/10915810252826028
Abstract
Transgenic mouse strains with genetic alterations known to play a role in the multistage process of carcinogenesis are being used increasingly as models for evaluating the human carcinogenic potential of chemicals and Pharmaceuticals. The Tg.AC transgenic mouse is one of the strains currently being used in such alternative short-term carcinogenicity testing protocols. This review is focused on recent data from studies designed to evaluate this model's ability to discriminate carcinogens from noncarcinogens. Details relating to protocol design that can significantly impact study outcome are described. Data relating to mechanisms of chemical tumor induction in the Tg.AC model are reviewed, and questions have been formulated to encourage research to further guide appropriate future applications of this model.Keywords
This publication has 64 references indexed in Scilit:
- Radial Transformation-Associated Recombination Cloning from the Mouse Genome: Isolation of Tg.AC Transgene with Flanking DNAsGenomics, 2000
- Oxymetholone: II. Evaluation in the Tg.AC Transgenic Mouse Model for Detection of CarcinogensToxicologic Pathology, 1999
- An Evaluation of the Hemizygous Transgenic Tg.AC Mouse for Carcinogenicity Testing of Pharmaceuticals. II. A Genotypic Marker that Predicts Tumorigenic ResponsivenessToxicologic Pathology, 1998
- The International Life Sciences Institute's Role in the Evaluation of Alternative Methodologies for the Assessment of Carcinogenic RiskToxicologic Pathology, 1998
- Association of v-Ha-ras Transgene Expression with Development of Erythroleukemia in Tg.AC Transgenic MiceThe American Journal of Pathology, 1998
- Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC miceCarcinogenesis: Integrative Cancer Research, 1996
- Regulation of the formation of the major diethylstilbestrol—DNA adduct and some evidence of its structureCarcinogenesis: Integrative Cancer Research, 1994
- Focal transgene expression associated with papilloma development in v-Ha-ras–transgenic TG.AC miceMolecular Carcinogenesis, 1994
- Tumor-promoting phorbol esters cause a stable reduction of dermal collagen in mouse skinEuropean Journal of Cancer and Clinical Oncology, 1987
- Carcinogenicity of phenacetin: Long‐term feeding study in B6C3F1 miceInternational Journal of Cancer, 1982